Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors.
The widely used atypical antipsychotic clozapine is a potent competitive antagonist at 5-HT(3) receptors which may contribute to its unique psychopharmacological profile. Clozapine binds to 5-HT(3) receptors of various species. However, the structural requirements of the respective binding site for...
Main Authors: | Gerhard Rammes, Christine Hosp, Brigitte Eisensamer, Sascha Tanasic, Caroline Nothdurfter, Walter Zieglgänsberger, Rainer Rupprecht |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-08-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2725292?pdf=render |
Similar Items
-
5-HT2A deletion protects against Clozapine-induced hyperglycemia
by: Radhika Sudhir Joshi, et al.
Published: (2019-02-01) -
The role of serotonin (5HT) and 5HT antagonists in urological cancers
by: Siddiqui, Emad Jawed
Published: (2007) -
Synthesis of Selective 5-HT6 and 5-HT7 Receptor Antagonists
by: Raux, Elizabeth A
Published: (2010) -
Synthesis of Selective 5-HT6 and 5-HT7 Receptor Antagonists
by: Raux, Elizabeth A
Published: (2010) -
Repeated Clozapine Increases the Level of Serotonin 5-HT1AR Heterodimerization with 5-HT2A or Dopamine D2 Receptors in the Mouse Cortex
by: Marta Szlachta, et al.
Published: (2018-02-01)